Are circulating endothelial cells the next target for transcriptome-level pathway analysis in ARDS
Related Posts
Cascavita CT, Hall AE, Shariati K, Chevalier JM, Argame AA, Nguyen NH, Tseng CH, Hidalgo MA, Lee JC; Craniofacial Outcomes Research Team. Exercise- and Nutrition-Based[...]
Mouabbi JA, Lipsyc-Sharf MD, Yan F. Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):1-16.[...]
Lipsyc-Sharf MD. Interpreting MRD results and integrating assays into practice. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):7-11. PMID: 42283708.